Finzati - Logo
VXRT logo

Vaxart, Inc.

VXRT • Biotechnology
$0.50
▲ +0.01 (+1.52%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$121.08M
Growth
-7.6%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 387.1%Positive free cash flow · 0.03Reasonable earnings multiple · 4.94Manageable debt level · 0.1Healthy liquidity · 1.57
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:00 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.50
Change1.52%
Shares Out242.17M
Market Cap$121.08M
Enterprise Value$64.91M
52W Range0.31 - 0.84
Beta1.10
P/E3.14
P/S0.50
P/B1.47
P/FCF3.63
EV/Sales0.27

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
54/100
Financial Strength
Debt, cash, stability
85/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Positive revenue growth · 387.1%Positive free cash flow · 0.03Reasonable earnings multiple · 4.94Manageable debt level · 0.1Healthy liquidity · 1.57

Analyst view

Analyst sentiment and price target

VXRT
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00

Company Overview

IPO: 12/11/1981
Industry: Biotechnology
P/B i: 1.47
Debt / Equity i: 0.10
Operating Margin: 7.62%
Net Margin: 6.88%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.10
Current Ratio: 1.57
Quick Ratio: 1.57
Status: Strong

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Finney Kevin
Transaction: 07/16/2026
BUY
Change
+78,700
Price
$0.51
Filing
07/20/2026
Type
BUY
Finney Kevin
Transaction: 07/16/2026
BUY
Change
+39,400
Price
Not reported
Filing
07/20/2026
Type
BUY
Wheadon David E.
Transaction: 07/16/2026
BUY
Change
+78,700
Price
$0.51
Filing
07/17/2026
Type
BUY